Biosenta Inc.
ZRO
CNSX
| 09/30/2024 | 06/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -199.86% | 146,200.00% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -199.86% | 146,200.00% | |||
| Cost of Revenue | 100.00% | 0.00% | |||
| Gross Profit | -199.93% | 146,200.00% | |||
| SG&A Expenses | -24.86% | 117.49% | |||
| Depreciation & Amortization | 0.00% | -58.33% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -25.10% | 103.99% | |||
| Operating Income | -164.98% | 2.18% | |||
| Income Before Tax | -30.90% | -8.93% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -30.90% | -8.93% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -30.90% | -8.93% | |||
| EBIT | -164.98% | 2.18% | |||
| EBITDA | -165.60% | 2.19% | |||
| EPS Basic | -17.99% | -3.73% | |||
| Normalized Basic EPS | -18.39% | -3.57% | |||
| EPS Diluted | -17.99% | -3.73% | |||
| Normalized Diluted EPS | -18.39% | -3.57% | |||
| Average Basic Shares Outstanding | 10.80% | 4.74% | |||
| Average Diluted Shares Outstanding | 10.80% | 4.74% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||
